Investors Hangout Stock Message Boards Logo
  • Home
  • Mailbox
  • Boards
  • Favorites
  • Whats Hot!
  • Login - Join Now!
Profile
sunray3's Profile
Displaying 1-50 of 181 result(s).
CYDY CytoDyn Inc
07/28/2025 12:02:02 PM
If so (not doubting you) then not h (4)
CYDY CytoDyn Inc
07/28/2025 11:18:19 AM
Thanks for the update on Dr C's sta (3)
CYDY CytoDyn Inc
07/25/2025 2:10:19 PM
Can some kind soul who remembers th (1)
CYDY CytoDyn Inc
07/24/2025 1:58:43 PM
Well said. Free leronlimab! (2)
CYDY CytoDyn Inc
07/23/2025 1:12:31 PM
Oh, I'm sure as I suspect you are t (7)
CYDY CytoDyn Inc
07/23/2025 12:07:51 PM
Now mind you, I don't pretend to kn (3)
CYDY CytoDyn Inc
07/23/2025 11:11:08 AM
Definitely BS, you're right...the M (7)
CYDY CytoDyn Inc
07/22/2025 10:36:07 AM
Well, I must admit that's a compell (11)
CYDY CytoDyn Inc
07/22/2025 9:05:38 AM
Agree, and as you say the acquirer (11)
CYDY CytoDyn Inc
07/03/2025 8:50:48 AM
Ah, good point. Thanks, I agree.
CYDY CytoDyn Inc
07/03/2025 1:08:38 AM
The question for me is does that la (4)
CYDY CytoDyn Inc
06/30/2025 2:48:01 PM
The chart price action has been int (9)
CYDY CytoDyn Inc
06/30/2025 1:09:38 PM
The ORR for TAS-102 and bevacizumab (4)
CYDY CytoDyn Inc
06/27/2025 1:52:44 PM
As I understand it and I've checked (8)
CYDY CytoDyn Inc
06/25/2025 11:11:13 AM
And yet here the Gates foundation i
CYDY CytoDyn Inc
06/24/2025 11:37:56 AM
Syneos as a clinical operations par (5)
CYDY CytoDyn Inc
06/23/2025 7:40:36 PM
Maybe. I agree with you about the m (2)
CYDY CytoDyn Inc
06/23/2025 1:48:54 PM
As per our previous conversation, w (2)
CYDY CytoDyn Inc
06/23/2025 11:58:40 AM
Just looked into it further, that w (1)
CYDY CytoDyn Inc
06/23/2025 10:58:00 AM
No, I think he's just congratulatin (1)
CYDY CytoDyn Inc
06/22/2025 3:25:09 PM
Heavens, I don't recall accusing an (4)
CYDY CytoDyn Inc
06/21/2025 11:31:19 AM
And way cheaper, you can be sure.
CYDY CytoDyn Inc
06/19/2025 4:10:48 PM
I'm no cardiologist, but I think th (3)
CYDY CytoDyn Inc
06/19/2025 11:22:48 AM
Glad you asked, some sources were s (2)
CYDY CytoDyn Inc
06/19/2025 1:05:54 AM
Yes, Dr Welch has many millions of (6)
CYDY CytoDyn Inc
06/17/2025 6:51:40 PM
Here's the link to the chart from m (2)
CYDY CytoDyn Inc
06/17/2025 6:32:13 PM
I can understand your thoughtful ob (2)
CYDY CytoDyn Inc
06/17/2025 12:43:00 PM
Yes to the first, no to the second. (7)
CYDY CytoDyn Inc
06/16/2025 9:58:58 AM
Pretty much, except that the two Me (1)
CYDY CytoDyn Inc
06/16/2025 2:33:07 AM
And let's not forget the PD-L1 bloc (7)
CYDY CytoDyn Inc
06/11/2025 3:41:44 PM
Nice reply, thanks. I agree general (9)
CYDY CytoDyn Inc
06/10/2025 2:00:30 PM
OK mods, this is that last one, I p (5)
CYDY CytoDyn Inc
06/10/2025 1:07:07 PM
I asked ChatGPT to analyze the leve (8)
CYDY CytoDyn Inc
06/10/2025 11:18:18 AM
Yeah, I guess that would be my poin (3)
CYDY CytoDyn Inc
06/10/2025 10:50:09 AM
And regarding the regulatory treatm (3)
CYDY CytoDyn Inc
06/10/2025 10:11:00 AM
I did some further research utilizi (4)
CYDY CytoDyn Inc
06/08/2025 10:52:28 AM
I agree, actually, and there's no w (7)
CYDY CytoDyn Inc
05/27/2025 10:39:42 AM
Touche, KC, that was hilarious, poi (4)
CYDY CytoDyn Inc
05/27/2025 9:29:27 AM
I agree. I use ChatGPT for research (3)
CYDY CytoDyn Inc
05/26/2025 7:34:40 PM
Interesting thought! In athe same v (12)
CYDY CytoDyn Inc
05/22/2025 1:51:52 PM
I understand what you're saying and (2)
CYDY CytoDyn Inc
05/19/2025 11:52:08 AM
I'm with you there, Max (ViiV/GSK) (2)
CYDY CytoDyn Inc
05/19/2025 11:10:11 AM
And if they wanted, Merck could rea (2)
CYDY CytoDyn Inc
05/18/2025 4:57:45 PM
Not being contrary here, but I just (2)
CYDY CytoDyn Inc
05/18/2025 1:35:11 PM
That got me to thinking about Leron (5)
CYDY CytoDyn Inc
05/18/2025 1:26:38 PM
I hear you. Still, Max Detaillade i (7)
CYDY CytoDyn Inc
05/18/2025 12:56:46 PM
I got one of those letters, and fro (5)
CYDY CytoDyn Inc
05/16/2025 6:41:46 PM
I got the same, it was for the cash (5)
CYDY CytoDyn Inc
05/13/2025 1:58:08 PM
I AI'ed that question a while ago i (3)
CYDY CytoDyn Inc
05/13/2025 10:34:33 AM
So well said. We owe so much to the (4)
Go to page:
  • << First
  • < Previous
  • 1
  • 2
  • Next >

Recent Articles

  • Exciting Moments as UNLEASHED Podcast Features Moto X Legends
  • Oklo Inc Experiences Stock Dip Following Remarkable Surge
  • Fortrea Holdings Investors: Class Action Insights and Guidance
  • KBR, Inc. Investors Under Investigation for Potential Fraud
  • Mandalay Resources Approves Major Transaction with Alkane
  • Investors Alert: Edgewise Therapeutics Under Scrutiny Amid Claims
  • Europcar Mobility Partners with OpenText for E-Invoicing
  • Securing Your Rights: A Guide for Reckitt Investors
  • Investors Urged to Seek Legal Rights After Rocket Pharmaceuticals Suit
  • Investing in Corteva: Tracking Growth Over Five Years
  • Important Legal Update for Investors in Vestis Corporation
  • The Potential Gold Revaluation: What It Means for Investors
  • Celebrating Dr. Rachel Elizabeth NeMoyer's Medical Achievements
  • Wanda Smith Earns 2025 Pinnacle Membership Recognition
  • Rubin and Rudman Celebrates Third Year of Women's Empowerment
  • Celebrating Academic Excellence: Daniel J. Chiego, Jr.
  • Celebrating Lawrence Steven Cosentino's Expertise and Impact
  • Revolutionary Waterfowl Decoy Design Enhances Hunting Experience
  • Kasowitz Expands IP Litigation Team with New Partners
  • 2025 Insights on Medicare Trends and Post-Acute Care Dynamics
  • Mill City Ventures (MCVT) Sees Dramatic Rise Following Crypto Venture
  • Understanding Legal Actions in Class Action Lawsuits
  • Analysts Show Optimism for GE Aerospace with Price Upgrades
  • VisionWave Secures $55 Million Funding to Boost Growth
  • BFC Partners Unveils New Affordable Housing Project in Coney Island
  • Warren Buffett's Portfolio: Is Apple Weighing It Down?
  • Unlocking the Amazing Growth of Amphenol's Stock Value
  • Understanding Market Sentiment for Kratos Defense & Security
  • Understanding Teradyne's Short Interest and Market Trends
  • Investor Insights: Analyzing UFP Industries' Short Interest Trends
  • Meta Platforms Inc. Earnings: Direxion ETFs Tell the Story
  • A Deep Dive into Philip Morris International's Stock Growth
  • Unlocking the Key to Successful Options Trading Strategies
  • Biohaven Ltd. Investors Encouraged to Join Securities Action
  • Neogen Corporation Faces Securities Fraud Class Action Lawsuit
  • EssilorLuxottica’s Robust Growth Proves Strong in 2025
  • Ekinops Reports Strong H1 2025 Results with Solid Margins
  • Nomura Holdings Set to Announce Quarterly Earnings Soon
  • Understanding DTE Energy's Upcoming Earnings Report Insights
  • Sysco Earnings on the Horizon: What Investors Need to Know
  • Exploring W.P. Carey's Future: Earnings Insights Ahead
  • Qualigen Therapeutics Secures $4.5 Million for Cancer Research
  • What to Expect from Arch Capital Group Earnings Report
  • CBRE Group Earnings Preview and Market Expectations Analysis
  • Essex Property Trust's Upcoming Q2 Earnings Preview and Insights
  • Corning's Upcoming Earnings Report and Market Expectations
  • Exploring the Financial Performance of Landstar System Inc
  • NEXTracker's Upcoming Earnings: Insights and Expectations
  • Polaris Inc: What Investors Should Expect This Quarter
  • EQT AB's Significant Share Buyback Overview for July 2025
  • Home - Investors HangoutHome

  • Mailbox - Investors HangoutMailbox

  • Boards - Investors HangoutBoards

  • Favorites - Investors HangoutFavorites

  • Whats Hot! - Investors HangoutWhats Hot!

  • More - Investors HangoutMore

  • Settings - Investors HangoutSettings
  • Login - Investors HangoutLogin
  • Live Site - Investors HangoutLive Site